Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 3/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3789476 | 0.94 | GRIK1 (0.50) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL29684744 | 0.92 | GPR84 (0.52) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL1162347 | 0.87 | CHRM1 (0.46) | SLC1A2SLC1A1SLC1A3CA2MAPK1 | |
| SCHEMBL15094143 | 0.81 | RNPEP (0.52) | SLC7A5HDAC1HDAC2 | |
| SCHEMBL15094144 | 0.81 | RNPEP (0.52) | SLC7A5HDAC1HDAC2 | |
| SCHEMBL31572071 | 0.78 | SLC1A2 (0.52) | SLC1A2SLC1A1SLC1A3CA2MAPK1 | |
| SCHEMBL6046246 | 0.78 | — | — | |
| SCHEMBL5323585 | 0.78 | — | — | |
| SCHEMBL19165268 | 0.77 | SLC1A2 (0.50) | SLC1A2SLC1A1SLC1A3CA2MAPK1 | |
| SCHEMBL21838063 | 0.77 | SLC1A2 (0.50) | SLC1A2SLC1A1SLC1A3CA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1663276-A4 | COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES | WYETH CORP (US) | 2009-02-18 | — | — | EP | claimed |
| CN-1849132-A | Compounds that modulate neuronal growth and their uses | KING S COLLEGE LONDON (GB) | 2006-10-18 | — | — | CN | claimed |
| EP-1663276-A2 | COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES | Wyeth (US) | 2006-06-07 | — | — | EP | claimed |
| WO-2005025514-A2 | COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES | KING'S COLLEGE LONDON (GB) | 2005-03-24 | — | — | WO | claimed |
| US-20030109454-A1 | Compounds and methods for modulating adhesion molecule function | ADHEREX TECHNOLOGIES, INC. (CA) | 2003-06-12 | — | — | US | claimed |
| US-20020193294-A1 | COMPOUNDS AND METHODS FOR MODULATING CLAUDIN-MEDIATED FUNCTIONS | ADHEREX TECHNOLOGIES INC. (CA) | 2002-12-19 | — | — | US | claimed |
| US-6031072-A | CYCLIC PEPTIDE WHICH MODULATES CADHERIN-MEDIATED PROCESSES; COMPRISING THE SEQUENCE HIS-ALA-VAL WITHIN A CYCLIC PEPTIDE RING THAT CONTAINS 4-15 AMINO ACIDS; FOR IMPROVED DRUG DELIVERY; ANTIMETASTASIS AGENTS | MCGILL UNIVERSITY (CA) | 2000-02-29 | — | — | US | claimed |
| WO-2018204385-A1 | COMBINATION THERAPY FOR CANCER | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2018-11-08 | — | — | WO | disclosed |
| CN-105828831-A | Novel peptide compositions | 塔瑞克斯制药有限公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-105451756-A | Angiotensin peptides in treating marfan syndrome and related disorders | TARIX PHARMACEUTICALS LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-104837485-A | Use of angiotensin in the treatment of brain conditions | TARIX PHARMACEUTICALS LTD | 2015-08-12 | — | — | CN | disclosed |
| CN-104394878-A | Compositions and methods for treatment of peripheral vascular disease | TARIX PHARMACEUTICALS LTD | 2015-03-04 | — | — | CN | disclosed |
| CN-104302305-A | Angiotensins for treatment of fibrosis | TARIX PHARMACEUTICALS LTD | 2015-01-21 | — | — | CN | disclosed |
| CN-1849132-A | Compounds that modulate neuronal growth and their uses | KING S COLLEGE LONDON (GB) | 2006-10-18 | — | — | CN | disclosed |
| EP-1651672-A2 | CYCLIC CADHERIN ANALOGUES COMPRISING THE SEQUENCE HAV FOR MODULATING THE MIGRATION OF VASCULAR SMOOTH MUSCLE CELLS | Adherex Technologies, Inc. (CA) | 2006-05-03 | — | — | EP | disclosed |
| US-20060084792-A1 | Versatile platform for nanotechnology based on circular permutations of chaperonin protein | USA AS REPRESENTED BY THE ADMINISTRATOR OF THE NASA | 2006-04-20 | — | — | US | disclosed |
| WO-2005012348-A2 | CYCLIC CADHERIN ANALOGUES COMPRISING THE SEQUENCE HAV FOR MODULATING THE MIGRATION OF VASCULAR SMOOTH MUSCLE CELLS | ADHEREX TECHNOLOGIES INC. (CA) | 2005-02-10 | — | — | WO | disclosed |
| EP-1311545-A2 | COMPOUNDS AND METHODS FOR MODULATING ENDOTHELIAL CELL ADHESION | McGILL UNIVERSITY (CA) | 2003-05-21 | — | — | EP | disclosed |
| WO-2001077146-A2 | COMPOUNDS AND METHODS FOR MODULATING ENDOTHELIAL CELL ADHESION | MCGILL UNIVERISTY (CA) | 2001-10-18 | — | — | WO | disclosed |
| WO-1995000544-A1 | METHOD AND COMPOSITION FOR TREATING THROMBOSIS | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109454-A1 | Compounds and methods for modulating adhesion molecule function | EPCAM, VCAM1, CDH1 | SLC1A2 3265/4885SLC1A1 3295/4885SLC1A3 3150/4885 |
| US-20020193294-A1 | COMPOUNDS AND METHODS FOR MODULATING CLAUDIN-MEDIATED FUNCTIONS | EPCAM, ICAM1, VCAM1 | SLC1A2 305/4885SLC1A1 312/4885SLC1A3 435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.